4 Results for "

PI3K/HDAC-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PI3K/HDAC-IN-1" in MCE Product Catalog:

Cat. No.: HY-128582
CAS No.: 2361418-52-0
Target:  

PI3K HDAC

Research Areas:  

Cancer

PI3K/HDAC-IN-1 is a potent dual inhibitor of PI3K/HDAC, potently inhibits PI3Kδ and HDAC1 with IC50s of 8.1 nM and 1.4 nM, respectively [1].
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-13522
CAS No.: 1339928-25-4
Purity:  99.95%
Synonyms: CUDC-907
Target:  

PI3K HDAC Apoptosis

Research Areas:  

Cancer

Fimepinostat (CUDC-907) potently inhibits class I PI3Ks as well as classes I and II HDAC enzymes with an IC50 of 19/54/39 nM and 1.7/5.0/1.8/2.8 nM for PI3Kα/PI3Kβ/PI3Kδ and HDAC1/HDAC2/HDAC3/HDAC10 , respectively.
loading...
    loading...
Cat. No.: HY-172889
CAS No.: 3085191-45-0
Target:  

PI3K HDAC Apoptosis mTOR Akt

Research Areas:  

Cancer

PI3K/HDAC-IN-4 (Compound 31f) is a PI3K/HDAC dual inhibitor (IC50: 0.2μM). PI3K/HDAC-IN-4 shows high selectivity for HDAC1-3 (IC50 values of 75.5 nM, 70.9 nM, and 1.9 nM, respectively). PI3K/HDAC-IN-4 is a potent PIK3 inhibitor with IC50 values of 2.5 nM, 80.5 nM, 10.0 nM, and 57.2 nM for PI3Kα, β, δ, and γ, respectively. PI3K/HDAC-IN-4 significantly induces tumor cell apoptosis by simultaneously inhibiting the PI3K/AKT/mTOR signaling pathway and HDAC1-3. PI3K/HDAC-IN-4 exhibits potent antiproliferative activity in a variety of tumor cell lines (e.g., MV4-11, Jeko-1, HL60, and MCF-7, with IC50 values of 0.2, 0.9, 0.8, and 1.5 μM, respectively). PI3K/HDAC-IN-4 can be used in the study of lymphoma and leukemia [1].
loading...
    loading...
Cat. No.: HY-155890
CAS No.: 1401998-36-4
Synonyms: CUDC-907 mesylate
Target:  

PI3K HDAC Apoptosis

Research Areas:  

Cancer

Fimepinostat mesylate potently inhibits class I PI3Ks as well as classes I and II HDAC enzymes with an IC50 of 19/54/39 nM and 1.7/5.0/1.8/2.8 nM for PI3Kα/PI3Kβ/PI3Kδ and HDAC1/HDAC2/HDAC3/HDAC10 , respectively.
loading...
    loading...